Published in Clin Pharmacol Ther on August 01, 2005
The genetics of type 2 diabetes: what have we learned from GWAS? Ann N Y Acad Sci (2010) 3.09
Genetic architecture of type 2 diabetes: recent progress and clinical implications. Diabetes Care (2009) 1.29
The pharmacogenetics of type 2 diabetes: a systematic review. Diabetes Care (2014) 1.03
Genetics of type 2 diabetes: insights into the pathogenesis and its clinical application. Biomed Res Int (2014) 0.92
Impact of genetic polymorphisms of leptin and TNF-alpha on rosiglitazone response in Chinese patients with type 2 diabetes. Eur J Clin Pharmacol (2008) 0.92
Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head-to-Head Randomized Clinical Studies. PPAR Res (2008) 0.90
Pharmacogenetics and personalized treatment of type 2 diabetes. Biochem Med (Zagreb) (2013) 0.89
Pharmacogenetics in type 2 diabetes: potential implications for clinical practice. Genome Med (2011) 0.87
Peroxisome proliferators-activated receptor γ2 Pro12Ala variant is associated with body mass index in non-alcoholic fatty liver disease patients. Hepatol Int (2010) 0.86
Pharmacogenetics of oral antidiabetic drugs. Int J Endocrinol (2013) 0.86
Personalized medicine in Type 2 Diabetes. Biomedicine (Taipei) (2014) 0.85
PPAR-γ2 and PTPRD gene polymorphisms influence type 2 diabetes patients' response to pioglitazone in China. Acta Pharmacol Sin (2012) 0.84
Personalized medicine in diabetes mellitus: current opportunities and future prospects. Ann N Y Acad Sci (2015) 0.83
Personalized pharmacotherapy for Type 2 diabetes mellitus. Per Med (2009) 0.83
PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease. PPAR Res (2008) 0.83
Genetic susceptibility to type 2 diabetes and implications for therapy. J Diabetes Sci Technol (2009) 0.82
PPARγ2 polymorphism and human health. PPAR Res (2009) 0.82
Influence of SLCO1B1 and CYP2C8 gene polymorphisms on rosiglitazone pharmacokinetics in healthy volunteers. Hum Genomics (2008) 0.81
Clinical translation of genetic predictors for type 2 diabetes. Curr Opin Endocrinol Diabetes Obes (2009) 0.81
Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine. Pharmgenomics Pers Med (2009) 0.81
Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents. Pharmgenomics Pers Med (2016) 0.79
Current clinical evidence on pioglitazone pharmacogenomics. Front Pharmacol (2013) 0.79
Pharmacogenomics in diabetes mellitus: insights into drug action and drug discovery. Nat Rev Endocrinol (2016) 0.79
Impact of GNB3-C825T, ADRB3-Trp64Arg, UCP2-3'UTR 45 bp del/ins, and PPARγ-Pro12Ala polymorphisms on Bofutsushosan response in obese subjects: a randomized, double-blind, placebo-controlled trial. J Med Food (2014) 0.77
Pharmacogenomics of Drug Response in Type 2 Diabetes: Toward the Definition of Tailored Therapies? PPAR Res (2015) 0.77
PPAR transcriptional activator complex polymorphisms and the promise of individualized therapy for heart failure. Heart Fail Rev (2008) 0.76
Genomic-based tools for the risk assessment, management, and prevention of type 2 diabetes. Appl Clin Genet (2015) 0.76
Pharmacogenetic studies update in type 2 diabetes mellitus. World J Diabetes (2016) 0.75
Patient profiling in diabetes and role of canagliflozin. Pharmgenomics Pers Med (2014) 0.75
Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs. Pharmacogenomics J (2016) 0.75
Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ (2004) 4.22
Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med (2004) 3.88
The effect of hypertension on the risk for kidney cancer in Korean men. Kidney Int (2005) 2.47
Serum alkaline phosphatase and phosphate in cerebral atherosclerosis and functional outcomes after cerebral infarction. Stroke (2013) 2.05
Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population. J Hum Genet (2008) 1.89
Antidiabetic agents from medicinal plants. Curr Med Chem (2006) 1.79
Changes in mortality after the recent economic crisis in South Korea. Ann Epidemiol (2004) 1.64
A novel degradable polycaprolactone networks for tissue engineering. Biomaterials (2003) 1.62
Prevalence of Diabetes and Prediabetes according to Fasting Plasma Glucose and HbA1c. Diabetes Metab J (2013) 1.61
Natural history of hepatitis B virus-related cirrhotic patients hospitalized to control ascites. J Gastroenterol Hepatol (2008) 1.55
NFkappaB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions. Proc Natl Acad Sci U S A (2008) 1.53
Serum cytokines and critical illness-related corticosteroid insufficiency. Intensive Care Med (2010) 1.51
Does birthweight predict adolescent adiponectin levels? Clin Endocrinol (Oxf) (2006) 1.49
β-Cell-protective effect of 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid as a glutamate dehydrogenase activator in db/db mice. J Endocrinol (2011) 1.47
Is prophylactic aortic valve replacement indicated during mitral valve surgery for mild to moderate aortic valve disease? Ann Thorac Surg (2002) 1.47
Safety and outcome after thrombolytic treatment in ischemic stroke patients with high-risk cardioembolic sources and prior subtherapeutic warfarin use. J Neurol Sci (2010) 1.43
Association between low-back pain and lumbar spine bone density: a population-based cross-sectional study. J Neurosurg Spine (2013) 1.42
ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1. J Biol Chem (2004) 1.41
Visceral fat thickness measured by ultrasonography can estimate not only visceral obesity but also risks of cardiovascular and metabolic diseases. Am J Clin Nutr (2004) 1.40
Stroke severity in concomitant cardiac sources of embolism in patients with atrial fibrillation. J Neurol Sci (2010) 1.38
Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults. J Korean Med Sci (2006) 1.38
Fucoidan present in brown algae induces apoptosis of human colon cancer cells. BMC Gastroenterol (2010) 1.37
Characteristics of body fat, body fat percentage and other body composition for Koreans from KNHANES IV. J Korean Med Sci (2011) 1.31
The association between sleep duration and general and abdominal obesity in Koreans: data from the Korean National Health and Nutrition Examination Survey, 2001 and 2005. Obesity (Silver Spring) (2009) 1.30
Soy food consumption and risk of prostate cancer: a meta-analysis of observational studies. Nutr Cancer (2009) 1.28
Effect of weight loss on some serum cytokines in human obesity: increase in IL-10 after weight loss. J Nutr Biochem (2007) 1.25
A randomized trial of mesenchymal stem cells in multiple system atrophy. Ann Neurol (2012) 1.24
Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice. J Biol Chem (2008) 1.24
Clinical features of bone metastases resulting from thyroid cancer: a review of 28 patients over a 20-year period. Endocr J (2005) 1.23
Korean red ginseng (Panax ginseng) improves insulin sensitivity and attenuates the development of diabetes in Otsuka Long-Evans Tokushima fatty rats. Metabolism (2009) 1.22
The risk of bladder cancer in korean diabetic subjects treated with pioglitazone. Diabetes Metab J (2012) 1.22
Diabetes epidemics in Korea: reappraise nationwide survey of diabetes "diabetes in Korea 2007". Diabetes Metab J (2013) 1.22
Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea. Metabolism (2005) 1.22
Smoking cessation and risk of type 2 diabetes mellitus: Korea Medical Insurance Corporation Study. Eur J Cardiovasc Prev Rehabil (2007) 1.20
Improved insulin sensitivity and adiponectin level after exercise training in obese Korean youth. Obesity (Silver Spring) (2007) 1.19
Predictive clinical parameters for the therapeutic efficacy of sitagliptin in korean type 2 diabetes mellitus. Diabetes Metab J (2011) 1.18
The association of total and differential white blood cell count with metabolic syndrome in type 2 diabetic patients. Diabetes Res Clin Pract (2006) 1.15
Glycated albumin is a useful glycation index for monitoring fluctuating and poorly controlled type 2 diabetic patients. Acta Diabetol (2010) 1.15
Comparison of tiotropium plus fluticasone propionate/salmeterol with tiotropium in COPD: a randomized controlled study. Respir Med (2011) 1.14
Micropropagation of Phalaenopsis orchids via protocorms and protocorm-like bodies. Methods Mol Biol (2011) 1.12
A report on the diagnosis of intermediate hyperglycemia in Korea: A pooled analysis of four community-based cohort studies. Diabetes Res Clin Pract (2008) 1.11
Red blood cell distribution width is associated with poor clinical outcome in acute cerebral infarction. Thromb Haemost (2012) 1.10
Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis. J Endocrinol (2007) 1.10
Peripheral effect of alpha-melanocyte-stimulating hormone on fatty acid oxidation in skeletal muscle. J Biol Chem (2006) 1.08
Development, validation, and responsiveness of a novel disease activity index for intestinal Behçet's disease. Inflamm Bowel Dis (2011) 1.08
The influence of adiponectin gene polymorphism on the rosiglitazone response in patients with type 2 diabetes. Diabetes Care (2005) 1.06
Effects of lifestyle modification on metabolic parameters and carotid intima-media thickness in patients with type 2 diabetes mellitus. Metabolism (2006) 1.06
Serum uric acid level is associated with metabolic syndrome and microalbuminuria in Korean patients with type 2 diabetes mellitus. J Diabetes Complications (2010) 1.06
The prevalence of the metabolic syndrome in Korean adults: comparison of WHO and NCEP criteria. Yonsei Med J (2005) 1.06
Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue-derived mesenchymal stem cell transplantation. Arthritis Rheum (2012) 1.05
Risk factors associated with the onset and progression of posttransplantation diabetes in renal allograft recipients. Diabetes Care (2007) 1.04
Reproductive risk factors for cardiovascular disease mortality among postmenopausal women in Korea: the Kangwha Cohort Study, 1985-2005. Menopause (2011) 1.04
Peroxisomal-proliferator-activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level. Biochem J (2004) 1.03
Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans. Metabolism (2007) 1.03
Transplantation of CTLA4Ig gene-transduced adipose tissue-derived mesenchymal stem cells reduces inflammatory immune response and improves Th1/Th2 balance in experimental autoimmune thyroiditis. J Gene Med (2011) 1.03
Effect of smoking on the paradox of high waist-to-hip ratio and low body mass index. Obes Res (2002) 1.02
Rosiglitazone protects human neuroblastoma SH-SY5Y cells against MPP+ induced cytotoxicity via inhibition of mitochondrial dysfunction and ROS production. J Neurol Sci (2007) 1.02